GoKawiilAntisense RNA therapy shows early promise in rare ALS case, plus US sanctions linked to Chinese patent surge
An antisense oligonucleotide therapy targeting the faulty CHCHD10 gene produced improved symptoms in the first ALS patient treated with it, who remained functional as a physician a year later. Separately, a study found that Chinese companies placed on the US Entity List appear to have increased their science patents and publications compared with non-sanctioned firms, though causation remains unproven.